Arrowhead Pharmaceuticals Inc (ARWR) returns
Arrowhead Pharmaceuticals returns over 10 years
$1,000 invested in Arrowhead Pharmaceuticals ten years ago was worth $10,213 at the close on October 30, 2026, with dividends reinvested: an average return of 26.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -8.5% | — | $915.20 | -0.9% |
| 3 months | -31.4% | — | $685.98 | +2.1% |
| Year to date | -9.8% | — | $902.24 | +11.7% |
| 1 year | +41.6% | — | $1,416 | +12.4% |
| 3 years | +158.0% | +37.1% | $2,580 | +88.5% |
| 5 years | -6.1% | -1.3% | $938.58 | +76.0% |
| 10 years | +921.3% | +26.2% | $10,213 | +316.6% |
Arrowhead Pharmaceuticals return by calendar year
| Year | ARWR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -9.8% | +11.7% | -21.5% |
| 2025 | +253.1% | +17.7% | +235.4% |
| 2024 | -38.6% | +24.9% | -63.4% |
| 2023 | -24.6% | +26.2% | -50.7% |
| 2022 | -38.8% | -18.2% | -20.7% |
| 2021 | -13.6% | +28.7% | -42.3% |
| 2020 | +21.0% | +18.4% | +2.6% |
| 2019 | +410.7% | +31.2% | +379.5% |
| 2018 | +237.5% | -4.6% | +242.1% |
| 2017 | +137.4% | +21.7% | +115.7% |
| 2016 | -74.8% | +12.0% | -86.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ARWR financials
No forecast, no recommendation. This page describes Arrowhead Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.